Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Chelsea Therapeutics International, Ltd. (CHTP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/25/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
06/25/2014 4 Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
06/25/2014 4 Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
06/25/2014 4 WEISER MICHAEL (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
Txns: Unknown transaction of 450,178 shares @ $0
Disposed/sold 27,500 shares @ $0
Exercised 27,500 options to buy @ $6.5, valued at $178.8k
Disposed/sold 52,500 options to buy @ $4.65, valued at $244.1k
Disposed/sold 52,500 options to buy @ $0.96, valued at $50.4k
Disposed/sold 17,500 options to buy @ $1.1, valued at $19.3k
Disposed/sold 35,000 options to buy @ $1.15, valued at $40.3k
Disposed/sold 30,000 options to buy @ $4.54, valued at $136.2k
Disposed/sold 30,000 options to buy @ $7.72, valued at $231.6k
Disposed/sold 30,000 options to buy @ $2.96, valued at $88.8k
Disposed/sold 30,000 options to buy @ $1.78, valued at $53.4k
06/25/2014 4 Clemens Kevan (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
Txns: Unknown transaction of 5,000 shares @ $0
Disposed/sold 35,000 options to buy @ $4.65, valued at $162.8k
Disposed/sold 35,000 options to buy @ $0.96, valued at $33.6k
Disposed/sold 35,000 options to buy @ $1.15, valued at $40.3k
Disposed/sold 40,000 options to buy @ $4.54, valued at $181.6k
Disposed/sold 40,000 options to buy @ $7.72, valued at $308.8k
Disposed/sold 40,000 options to buy @ $2.96, valued at $118.4k
Disposed/sold 40,000 options to buy @ $1.78, valued at $71.2k
Disposed/sold 42,500 options to buy @ $6.5, valued at $276.3k
Disposed/sold 42,500 options to buy @ $5.68, valued at $241.4k
Disposed/sold 30,000 options to buy @ $3.26, valued at $97.8k
06/25/2014 4 Schmidt Keith (Chief Commercial Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
06/25/2014 4 Roberts Michael J (VP, Business Development) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
06/25/2014 4 Oliveto Joseph (President and CEO) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
06/25/2014 4 Riehle J Nick (CFO) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
Txns: Unknown transaction of 66,183 shares @ $0
Disposed/sold 368,923 shares @ $0
Exercised 50,000 options to buy @ $6.5, valued at $325k
Exercised 50,000 options to buy @ $3.26, valued at $163k
Exercised 50,000 options to buy @ $2.96, valued at $148k
Exercised 68,923 options to buy @ $2.62, valued at $180.6k
Exercised 50,000 options to buy @ $1.78, valued at $89k
Exercised 50,000 options to buy @ $1.24, valued at $62k
Exercised 50,000 options to buy @ $0.96, valued at $48k
Disposed/sold 50,000 options to buy @ $7.72, valued at $386k
Disposed/sold 50,000 options to buy @ $5.68, valued at $284k
06/25/2014 4 Schwieterman William D (Chief Medical Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.
Txns: Unknown transaction of 130,592 shares @ $0
Disposed/sold 350,000 shares @ $0
Exercised 35,000 options to buy @ $5.07, valued at $177.5k
Exercised 50,000 options to buy @ $4.65, valued at $232.5k
Exercised 50,000 options to buy @ $4.54, valued at $227k
Exercised 10,000 options to buy @ $2.96, valued at $29.6k
Exercised 75,000 options to buy @ $2.82, valued at $211.5k
Exercised 30,000 options to buy @ $1.78, valued at $53.4k
Exercised 50,000 options to buy @ $1.24, valued at $62k
Exercised 50,000 options to buy @ $0.96, valued at $48k
Disposed/sold 50,000 options to buy @ $7.72, valued at $386k
06/23/2014 8-K Form 8-K - Current report
06/23/2014 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/23/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/19/2014 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/19/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/11/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/06/2014 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/06/2014 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/28/2014 SC 13G RTW INVESTMENTS, LLC reports a 5.4% stake in Chelsea Therapeutics International Ltd.
05/23/2014 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
05/23/2014 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
05/12/2014 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/12/2014 8-K Other Events
05/09/2014 10-Q Quarterly Report for the period ended March 31, 2014
05/08/2014 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/08/2014 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
05/08/2014 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
05/08/2014 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Chelsea Therapeutics International, Ltd., H. Lundbeck A/S and Charlie Acquisition Corp",
"Form of Contingent Value Rights Agreement",
"Lundbeck to acquire Chelsea Therapeutics"
04/30/2014 10-K/A Annual Report for the period ended December 31, 2013 [amend]
03/11/2014 10-K Annual Report for the period ended December 31, 2013
02/18/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA TM for the Treatment of Symptomatic NOH"
02/14/2014 SC 13G/A VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 2.4% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD.
02/14/2014 SC 13G BAKER BROS. ADVISORS LP reports a 8.2% stake in Chelsea Therapeutics International, Ltd.
02/14/2014 8-K Regulation FD Disclosure
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy